甲狀腺消融設備市場報告：趨勢、預測和競爭分析（至 2031 年）

全球甲狀腺消融設備市場前景光明，醫院、門診手術中心和專科癌症中心市場都存在機會。預計全球甲狀腺消融設備市場從 2025 年到 2031 年的複合年成長率將達到 9.7%。該市場的主要驅動力是甲狀腺癌發病率的上升以及對微創手術的趨勢日益增強。

• Lucintel 預測，射頻消融術在預測期內仍將佔據主要地位，因為它具有快速、安全、微創等優勢，可以作為手術的替代方案。
• 根據最終用途，醫院預計仍將是最大的部分。
• 從地區來看，由於甲狀腺癌發病率上升以及該地區主要公司的存在，預計北美將在預測期內繼續成為最大的地區。

甲狀腺消融設備市場的策略性成長機會

甲狀腺消融設備市場為希望利用日益成長的微創治療需求的相關人員提供了眾多策略性成長機會。隨著人們對甲狀腺疾病認知的提高和技術創新的進步，出現了幾種擴展途徑。利用這些機會可以幫助公司擴大市場佔有率、推動永續成長，同時改善患者的治療效果。

• 擴展到新興市場：新興市場，尤其是亞洲和拉丁美洲，由於醫療保健投資的增加和人們對甲狀腺健康的認知的提高，提供了巨大的成長潛力，為公司擴展業務提供了途徑。
• 開發聯合治療：有機會開發將切除術與其他治療方法（例如荷爾蒙療法或標靶藥物療法）相結合的聯合治療，這可能會提高整體療效和患者滿意度。
• 專注於以患者為中心的解決方案：公司可以投資以患者為中心的解決方案，例如教育計劃和支援服務，以提高患者的參與度和意識，最終推動對切除術的需求。
• 策略夥伴關係和合作：與醫療保健提供者、研究機構和技術公司建立策略夥伴關係可以促進創新、擴大新設備的分銷、提高市場滲透率並共用專業知識。
• 投資研發：持續投資研發對於推進消融技術、滿足不斷變化的臨床需求以及推出改善治療結果的新設備至關重要。

甲狀腺消融設備市場的策略性成長機會對於製造商和醫療保健提供者來說都是有利的。透過專注於擴張、創新和協作，相關人員不僅可以提高其市場地位，還可以為改善甲狀腺管理中的患者照護做出重大貢獻。

甲狀腺消融設備市場促進因素與挑戰

在幾個關鍵促進因素的推動下，甲狀腺消融設備市場正在經歷顯著成長。同時，影響市場擴張的挑戰依然存在。了解這些動態對於相關人員有效駕馭不斷發展的甲狀腺治療格局至關重要。確定成長催化劑和需要克服的障礙將有助於在這個競爭激烈的市場中做出策略決策。

推動甲狀腺消融設備市場發展的因素有：

• 甲狀腺疾病盛行率不斷上升：甲狀腺疾病（包括甲狀腺結節和癌症）盛行率不斷上升，推動了對有效治療方案的需求，使甲狀腺消融成為醫療保健提供者中越來越受歡迎的選擇。
• 微創技術的進步：射頻消融術和微波消融等微創消融技術的創新吸引了尋求微創手術的患者，促進了市場的成長和普及。
• 提高意識和教育：患者和醫療保健專業人員對甲狀腺健康和可用治療方案的認知不斷提高，這推動了對甲狀腺消融療法的需求並提高了市場意識。
• 支持性法規環境：有利的法規環境和加速的新設備核准流程鼓勵製造商創新並將先進產品推向市場，進一步刺激成長。
• 擴大門診照護模式：向門診照護模式的轉變正在擴大切除術的可近性。患者喜歡較短的恢復時間和可以在醫院外進行的侵入性較小的治療。

甲狀腺消融設備市場面臨的主要挑戰是：

• 設備高成本：特別是在對成本敏感的醫療保健市場中，先進的甲狀腺消融設備的高成本可能會成為採用的障礙，限制一些患者和醫療保健提供者的獲取。
• 臨床指引的差異：不同地區不同的臨床指引和治療通訊協定可能會造成醫療保健提供者的混亂，並阻礙甲狀腺消融技術的廣泛應用。
• 患者認知度低：儘管認知度不斷提高，但許多患者仍然不知道甲狀腺消融是一種治療選擇，這可能會減緩這種創新治療方法在臨床實踐中的應用。

總之，甲狀腺消融設備市場受到技術進步和患者意識增強等多種強勁促進因素的支持。然而，高成本和不一致的指導方針等挑戰可能會阻礙成長。對於希望在這個不斷發展的市場中發揮最大影響力的相關人員來說，應對這些挑戰並利用已確定的促進因素至關重要。

目錄

第1章執行摘要

2. 全球甲狀腺消融設備市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球甲狀腺消融設備市場趨勢（2019-2024）及預測（2025-2031）
• 全球甲狀腺消融設備市場（按類型）
  • 射頻消融術
  • 微波消融
  • 其他
• 全球甲狀腺消融設備市場（按產品）
  • 熱敏設備
  • 非熱能設備
• 全球甲狀腺消融設備市場（按應用）
  • 甲狀腺癌
  • 甲狀腺結節
  • 其他
• 全球甲狀腺消融設備市場（依最終用途）
  • 醫院
  • 門診手術中心
  • 癌症中心
  • 其他

第4章區域市場趨勢與預測分析（2019-2031）

• 全球甲狀腺消融設備市場（按地區）
• 北美甲狀腺消融設備市場
• 歐洲甲狀腺消融設備市場
• 亞太甲狀腺消融設備市場
• 世界其他地區甲狀腺消融設備市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球甲狀腺消融設備市場成長機會（按類型）
  • 全球甲狀腺消融設備市場成長機會（按產品）
  • 全球甲狀腺消融設備市場的成長機會（按應用）
  • 全球甲狀腺消融設備市場成長機會（依最終用途）
  • 全球甲狀腺消融設備市場各區域成長機會
• 全球甲狀腺消融設備市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球甲狀腺消融設備市場產能擴張
  • 全球甲狀腺消融設備市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

The future of the global thyroid ablation device market looks promising, with opportunities in the hospital, ambulatory surgical center, and cancer specialty center markets. The global thyroid ablation device market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing incidence of thyroid cancer and the rising inclination toward minimally invasive procedures.

• Lucintel forecasts that, within the type category, radiofrequency ablation will remain the larger segment over the forecast period due to its advantages, like being quick, safe, and less invasive substitutes for surgery.
• Within the end use category, the hospital will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to the rising incidence of thyroid cancer and the existence of key players in the region.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Thyroid Ablation Device Market

The thyroid ablation device market is rapidly evolving, influenced by technological advancements, changing patient preferences, and growing awareness of thyroid-related health issues. As healthcare professionals seek more effective and minimally invasive treatment options, several emerging trends are shaping the future of this market. These trends reflect innovations in device design, treatment methodologies, and patient care strategies, promising improved outcomes for individuals with thyroid disorders.

• Increased Adoption of Radiofrequency Ablation: Radiofrequency ablation (RFA) is gaining traction due to its minimally invasive nature, allowing for targeted destruction of thyroid nodules while preserving surrounding tissue. This leads to quicker recovery times for patients.
• Advancements in Imaging Techniques: Enhanced imaging technologies, such as ultrasound and CT scans, are playing a crucial role in improving the precision of thyroid ablation procedures, enabling better visualization of nodules and real-time monitoring during treatments.
• Development of Novel Devices: Manufacturers are focusing on the development of innovative ablation devices that combine multiple modalities, such as laser and microwave technologies, to improve efficacy, reduce procedure times, and expand treatment indications.
• Growing Patient Awareness: Increased awareness of thyroid disorders and treatment options is driving patient demand for minimally invasive procedures, prompting healthcare providers to adopt ablation techniques as a preferred choice over traditional surgery.
• Regulatory Support for New Technologies: Regulatory bodies are increasingly supportive of novel thyroid ablation devices, expediting approval processes and encouraging research and development. This is likely to spur market growth and innovation in the coming years.

The thyroid ablation device market is witnessing dynamic changes driven by these emerging trends. As technology continues to advance and patient needs evolve, the focus on minimally invasive and effective treatment options will likely dominate the market landscape, ultimately improving patient outcomes and satisfaction.

Recent Developments in the Thyroid Ablation Device Market

The thyroid ablation device market has seen remarkable developments in recent years, driven by technological innovation and an increasing focus on minimally invasive treatment options. These advancements aim to enhance patient outcomes, improve procedural efficiency, and expand the range of treatable conditions. As healthcare providers adopt these innovations, they are reshaping the landscape of thyroid management, providing patients with safer and more effective treatment alternatives.

• Launch of Advanced Ablation Systems: Recent launches of advanced ablation systems featuring improved radiofrequency and microwave technologies are enhancing precision in targeting thyroid nodules, leading to better outcomes and reduced complications.
• Integration of Artificial Intelligence: The integration of artificial intelligence in imaging and procedural planning is revolutionizing thyroid ablation, allowing for more accurate diagnoses and optimized treatment strategies, which significantly improve procedural success rates.
• Growth of Outpatient Procedures: There is a notable shift toward outpatient thyroid ablation procedures, driven by advancements in technology that enable faster recovery and reduced hospital stays, aligning with patient preferences for less invasive treatments.
• Expansion of Clinical Indications: New clinical studies are supporting the use of thyroid ablation for a broader range of indications, including larger nodules and recurrent cases, thereby expanding the patient population eligible for these minimally invasive therapies.
• Regulatory Approvals for Novel Devices: Recent regulatory approvals for innovative thyroid ablation devices are encouraging manufacturers to invest in research and development, fostering a competitive environment that enhances the overall quality and effectiveness of available treatments.

The recent developments in the thyroid ablation device market signal a transformative period for thyroid care. With advancements in technology, procedural approaches, and regulatory support, the future of thyroid management looks promising, offering patients safer and more effective treatment options tailored to their specific needs.

Strategic Growth Opportunities for Thyroid Ablation Device Market

The thyroid ablation device market presents numerous strategic growth opportunities for stakeholders seeking to capitalize on increasing demand for minimally invasive treatments. As awareness of thyroid disorders rises and technological innovations emerge, there are several avenues for expansion. By leveraging these opportunities, companies can enhance their market presence and drive sustainable growth while improving patient care outcomes.

• Expansion into Emerging Markets: Emerging markets, particularly in Asia and Latin America, offer significant growth potential due to rising healthcare investments and increasing awareness of thyroid health, providing an avenue for companies to expand their reach.
• Development of Combination Therapies: There is an opportunity to develop combination therapies that integrate thyroid ablation with other treatment modalities, such as hormonal therapy or targeted drug treatments, which could enhance overall efficacy and patient satisfaction.
• Focus on Patient-Centric Solutions: Companies can invest in patient-centric solutions, such as educational programs and support services, to increase patient engagement and awareness, ultimately driving demand for thyroid ablation procedures.
• Strategic Partnerships and Collaborations: Forming strategic partnerships with healthcare providers, research institutions, and technology firms can facilitate innovation and broaden the distribution of new devices, enhancing market penetration and fostering shared expertise.
• Investment in Research and Development: Continued investment in research and development is crucial for advancing ablation technologies and techniques, enabling the introduction of novel devices that meet evolving clinical needs and improve treatment outcomes.

The strategic growth opportunities within the thyroid ablation device market are promising for manufacturers and healthcare providers alike. By focusing on expansion, innovation, and collaboration, stakeholders can not only enhance their market positions but also significantly contribute to improved patient care in thyroid management.

Thyroid Ablation Device Market Driver and Challenges

The thyroid ablation device market is experiencing significant growth, propelled by several key drivers. At the same time, challenges remain that could impact market expansion. Understanding these dynamics is crucial for stakeholders aiming to navigate the evolving landscape of thyroid care effectively. Identifying both the catalysts for growth and the hurdles to overcome will help inform strategic decisions in this competitive market.

The factors responsible for driving the thyroid ablation device market include:

• Increasing Prevalence of Thyroid Disorders: The rising incidence of thyroid disorders, including nodules and cancer, is driving demand for effective treatment options, making thyroid ablation an increasingly popular choice among healthcare providers.
• Advancements in Minimally Invasive Techniques: Innovations in minimally invasive ablation technologies, such as radiofrequency and microwave ablation, are attracting patients seeking less invasive procedures, contributing to the market's growth and adoption.
• Growing Awareness and Education: Increased awareness of thyroid health and available treatment options among patients and healthcare professionals is fostering greater demand for thyroid ablation procedures, enhancing market visibility.
• Supportive Regulatory Environment: A favorable regulatory environment, with expedited approval processes for new devices, encourages manufacturers to innovate and bring advanced products to market, further driving growth.
• Expanding Outpatient Treatment Models: The shift toward outpatient care models is facilitating greater access to thyroid ablation procedures, as patients prefer shorter recovery times and less invasive options that can be performed outside of hospital settings.

Challenges in the thyroid ablation device market are:

• High Cost of Devices: The high cost associated with advanced thyroid ablation devices can be a barrier to adoption, particularly in cost-sensitive healthcare markets, limiting access for some patients and providers.
• Variability in Clinical Guidelines: Variability in clinical guidelines and treatment protocols across different regions can create confusion among healthcare providers, potentially hindering the widespread adoption of thyroid ablation techniques.
• Limited Awareness Among Patients: Despite growing awareness, many patients remain uninformed about thyroid ablation as a treatment option, which can slow down the uptake of these innovative therapies in clinical practice.

In conclusion, the thyroid ablation device market is buoyed by several strong drivers, including technological advancements and increasing patient awareness. However, challenges such as high costs and variability in guidelines may impede growth. Addressing these challenges while leveraging the identified drivers will be essential for stakeholders aiming to maximize their impact in this evolving market.

List of Thyroid Ablation Device Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, thyroid ablation device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid ablation device companies profiled in this report include-

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

Thyroid Ablation Device by Segment

The study includes a forecast for the global thyroid ablation device market by type, product, application, end use, and region.

Thyroid Ablation Device Market by Type [Analysis by Value from 2019 to 2031]:

• Radiofrequency Ablation
• Microwave Ablation
• Others

Thyroid Ablation Device Market by Product [Analysis by Value from 2019 to 2031]:

• Thermal Based Devices
• Non-Thermal Based Devices

Thyroid Ablation Device Market by Application [Analysis by Value from 2019 to 2031]:

• Thyroid Cancer
• Thyroid Nodules
• Others

Thyroid Ablation Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Cancer Specialty Centers
• Others

Thyroid Ablation Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Thyroid Ablation Device Market

The thyroid ablation device market has seen significant advancements recently, driven by technological innovations, the increasing prevalence of thyroid disorders, and growing awareness of minimally invasive treatment options. These developments are shaping the landscape of healthcare across various countries, including the United States, China, Germany, India, and Japan. Each of these markets is experiencing unique trends that reflect their healthcare needs and economic conditions, fostering a competitive environment for device manufacturers and healthcare providers.

• United States: The U.S. market is witnessing rapid growth due to advancements in ultrasound-guided radiofrequency ablation technology, leading to increased adoption of these procedures among endocrinologists and surgeons.
• China: The thyroid ablation device market in China is expanding quickly, propelled by rising healthcare investments and a growing patient population seeking effective treatments for thyroid nodules and cancer.
• Germany: The German market is characterized by a strong emphasis on research and development, with local manufacturers innovating new technologies to improve efficacy and patient outcomes in thyroid ablation procedures.
• India: The thyroid ablation market in India is evolving as awareness of non-surgical treatment options grows, supported by the increasing incidence of thyroid disorders and the entry of international players into the healthcare sector.
• Japan: Japan is experiencing a surge in thyroid ablation procedures, driven by advancements in imaging technologies and a shift towards minimally invasive treatments, leading to improved patient satisfaction and outcomes.

Features of the Global Thyroid Ablation Device Market

Market Size Estimates: Thyroid ablation device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Thyroid ablation device market size by various segments, such as by type, product, application, end use, and region in terms of value ($B).

Regional Analysis: Thyroid ablation device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end uses, and regions for the thyroid ablation device market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the thyroid ablation device market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid ablation device market by type (radiofrequency ablation, microwave ablation, and others), product (thermal based devices and non-thermal based devices), application (thyroid cancer, thyroid nodules, and others), end use (hospitals, ambulatory surgical centers, cancer specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Ablation Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Thyroid Ablation Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Thyroid Ablation Device Market by Type
  • 3.3.1: Radiofrequency Ablation
  • 3.3.2: Microwave Ablation
  • 3.3.3: Others
• 3.4: Global Thyroid Ablation Device Market by Product
  • 3.4.1: Thermal Based Devices
  • 3.4.2: Non-Thermal Based Devices
• 3.5: Global Thyroid Ablation Device Market by Application
  • 3.5.1: Thyroid Cancer
  • 3.5.2: Thyroid Nodules
  • 3.5.3: Others
• 3.6: Global Thyroid Ablation Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Cancer Specialty Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Thyroid Ablation Device Market by Region
• 4.2: North American Thyroid Ablation Device Market
  • 4.2.1: North American Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.3: European Thyroid Ablation Device Market
  • 4.3.1: European Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.4: APAC Thyroid Ablation Device Market
  • 4.4.1: APAC Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.5: ROW Thyroid Ablation Device Market
  • 4.5.1: ROW Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Thyroid Ablation Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Thyroid Ablation Device Market by Product
  • 6.1.3: Growth Opportunities for the Global Thyroid Ablation Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Thyroid Ablation Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Thyroid Ablation Device Market by Region
• 6.2: Emerging Trends in the Global Thyroid Ablation Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Thyroid Ablation Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Ablation Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific Corporation
• 7.2: BVM Medical System
• 7.3: Integra Life Sciences
• 7.4: Johnson & Johnson
• 7.5: Medtronic
• 7.6: MedWaves
• 7.7: Olympus Corporation
• 7.8: StarMed
• 7.9: Terumo Europe
• 7.10: Theraclion